FdaApplication
NDA 215814
Identifiers
- fda_app_no: NDA215814
Properties
| Property | Value |
|---|---|
| applicant_name | RIGEL PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2022-12-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REZLIDHIA | OLUTASIDENIB | 150MG | CAPSULE;ORAL |
1 product